Loading stock data…
$6.42+0.27 (+4.39%)
Alpha Teknova, Inc.
Alpha Teknova, Inc. in the Healthcare sector is trading at $6.42 with a market capitalization of $418M. Wall Street consensus targets $9.67 (6 analysts), implying a +50.6% move over the next 12 months. The stock is currently 32% below its 52-week high of $9.48, remaining 33.8% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 27 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $12.19M↑ | $11.08M↑ | $9.98M↓ | $10.45M↑ | $10.29M |
| Gross Profit | $4.88M↑ | $3.78M↑ | $3.24M↑ | $3.21M↓ | $3.98M |
| Operating Income | -$2.89M↑ | -$4.30M↑ | -$4.61M↓ | -$4.02M↓ | -$3.39M |
| Net Income | -$3.17M↑ | -$4.55M↑ | -$4.76M↓ | -$4.29M↓ | -$3.57M |
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured me...